2025 HCPCS Code J9349
Injection, tafasitamab-cxix, 2 mg
| Short Description | Inj., tafasitamab-cxix |
| HCPCS Action Code | N - No maintenance for this code |
| HCPCS Coverage Code | C - Carrier judgment |
| HCPCS Code Added Date | April 01, 2021 |
| HCPCS Action Effective Date | April 01, 2021 |
| HCPCS Pricing Indicator Code | 51 - Drugs |
| HCPCS Type Of Service Code | 1 - Medical care |
| HCPCS Multiple Pricing Indicator Code | A - Not applicable as HCPCS priced under one methodology |
| HCPCS Anesthesia Base Unit Quantity | 0 |
| HCPCS Coverage Issues Manual Reference Section Number |
Check Similar HCPCS Codes
- J9260 - Inj methotrexate sodium 50mg
- J9261 - Nelarabine injection
- J9262 - Inj, omacetaxine mep, 0.01mg
- J9263 - Oxaliplatin
- J9264 - Paclitaxel protein bound
- J9265 - Paclitaxel injection
- J9266 - Pegaspargase injection
- J9267 - Paclitaxel injection
- J9268 - Pentostatin injection
- J9269 - Inj. tagraxofusp-erzs 10 mcg
- J9270 - Plicamycin (mithramycin) inj
- J9271 - Inj pembrolizumab
- J9272 - Inj, dostarlimab-gxly, 10 mg
- J9273 - Inj tisotu vedotin-tftv, 1mg
- J9274 - Inj, tebentafusp-tebn, 1 mcg
- J9275 - Inj cosibelimab-ipdl, 2 mg
- J9276 - Inj zanidatamab-hrii, 2 mg
- J9280 - Mitomycin injection
- J9281 - Mitomycin instillation
- J9285 - Inj, olaratumab, 10 mg